Iaso Therapeutics is focused on development of novel technologies for next generation vaccines including vaccines targeting cancer & infectious diseases.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 10.02.2023 | Seed | $1.25M | - |
Mentions in press and media 4
| Date | Title | Description |
| 27.01.2023 | StartUPDATES: New Developments from Healthcare Startups | Carrum Health is collaborating with University of Chicago Medicine to bring value-based breast cancer treatment and care to self-insured employers and their employees in the Midwest. Eligible patients can now receive treatment for non-metas... |
| 26.01.2023 | Iaso Therapeutics Holds First Close Of $1.25M Seed Financing | Iaso Therapeutics, an East Lansing, MI-based startup developing novel technologies for vaccines, closed the first tranche of its $1.25M Seed funding.
The round was led by Michigan Rise Pre-Seed III Fund, Red Cedar Ventures Pre-Seed Fund and... |
| 25.01.2023 | Iaso Therapeutics Inks First Close in $1.25M Seed |
EAST LANSING, MI, Iaso Therapeutics recently closed the first tranche of the company's $1.25M Series Seed Preferred round of financing.
>> Click here for more funding data on Iaso Therapeutics
>> To export Iaso Therapeutics ... |
| - | Iaso Therapeutics | “Iaso Therapeutics is focused on development of novel technologies for next generation vaccines including vaccines targeting cancer & infectious diseases.” |
Reviews 0
